ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Return
7.83%
This Quarter Return
-19.19%
1 Year Return
-7.83%
3 Year Return
+43.87%
5 Year Return
+57.06%
10 Year Return
–
AUM
$295M
AUM Growth
-$221M
(-43%)
Cap. Flow
-$89.7M
Cap. Flow
% of AUM
-30.36%
Top 10 Holdings %
Top 10 Hldgs %
27.71%
Holding
723
New
68
Increased
129
Reduced
187
Closed
39
Top Buys
| 1 |
iShares MSCI Poland ETF
EPOL
|
$7.31M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$7.19M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
$5.93M |
| 4 |
iShares MSCI Turkey ETF
TUR
|
$5.1M |
| 5 |
Alibaba
BABA
|
$3.19M |
Top Sells
| 1 |
UBS Group
UBS
|
$19.6M |
| 2 |
Ferrari
RACE
|
$13M |
| 3 |
Stellantis
STLA
|
$8.96M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
$8.53M |
| 5 |
iShares MSCI Malaysia ETF
EWM
|
$8.5M |
Sector Composition
| 1 | Healthcare | 13.66% |
| 2 | Technology | 12.53% |
| 3 | Financials | 10.07% |
| 4 | Consumer Discretionary | 8.45% |
| 5 | Communication Services | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
276
Barrick Mining Corporation
B
$48.5B
| $87.8K | 0.02% |
4,790
-20,192
| -81% | -$370K |
|
277
Target
TGT
$42.3B
| $87.2K | 0.02% |
938
-580
| -38% | -$53.9K |
|
278
Krystal Biotech
KRYS
$4.35B
| $87.2K | 0.02% |
+2,016
| New | +$87.2K |
|
279
SPDR S&P Regional Banking ETF
KRE
$3.99B
| $86.8K | 0.02% |
2,665
| – | – |
|
280
Nike
NKE
$109B
| $86.1K | 0.02% |
1,041
+39
| +4% | +$3.23K |
|
281
Electronic Arts
EA
$42.2B
| $85.9K | 0.02% |
858
-1,023
| -54% | -$102K |
|
|
CCXI
282
DELISTED
ChemoCentryx, Inc.
CCXI
| $85.5K | 0.02% |
+2,129
| New | +$85.5K |
|
|
APHA
283
DELISTED
Aphria Inc. Common Shares
APHA
| $84.1K | 0.02% |
27,481
+10,846
| +65% | +$33.2K |
|
|
MYOK
284
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $83.9K | 0.02% |
+1,790
| New | +$83.9K |
|
285
Lumen
LUMN
$4.87B
| $82K | 0.02% |
8,666
-263,963
| -97% | -$2.5M |
|
286
IAMGOLD
IAG
$5.7B
| $80.5K | 0.02% |
35,305
-3,923
| -10% | -$8.94K |
|
287
Nucor
NUE
$33.8B
| $80.1K | 0.02% |
2,224
-63,994
| -97% | -$2.31M |
|
288
Phathom Pharmaceuticals
PHAT
$875M
| $80.1K | 0.02% |
+3,102
| New | +$80.1K |
|
289
General Motors
GM
$55.5B
| $79.5K | 0.02% |
3,827
+1,300
| +51% | +$27K |
|
290
Merit Medical Systems
MMSI
$5.51B
| $78.2K | 0.02% |
+2,504
| New | +$78.2K |
|
291
Newmont
NEM
$83.7B
| $77.9K | 0.02% |
1,720
-6,053
| -78% | -$274K |
|
292
SSR Mining
SSRM
$4.28B
| $77.4K | 0.02% |
6,848
| – | – |
|
293
Tilray
TLRY
$1.31B
| $76.9K | 0.02% |
11,160
-2,500
| -18% | -$17.2K |
|
294
AGNC Investment
AGNC
$10.8B
| $76.7K | 0.02% |
7,252
| – | – |
|
295
Axsome Therapeutics
AXSM
$6.25B
| $76.5K | 0.02% |
+1,300
| New | +$76.5K |
|
296
Vanguard Energy ETF
VDE
$7.2B
| $76.4K | 0.02% |
+2,000
| New | +$76.4K |
|
|
FSTX
297
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $75.9K | 0.02% |
+20,400
| New | +$75.9K |
|
298
PTC Therapeutics
PTCT
$4.55B
| $75.4K | 0.02% |
1,691
-251
| -13% | -$11.2K |
|
|
ATRS
299
DELISTED
Antares Pharma, Inc.
ATRS
| $75.1K | 0.02% |
+31,811
| New | +$75.1K |
|
300
Abbott
ABT
$231B
| $75K | 0.02% |
950
-192
| -17% | -$15.2K |
|